BDBM664557 (2R,3R,4S,5R,6R)-6-((1-((3S*,4R*)-3-fluorotetrahydro-2H-pyran-4-yl)-1H-1,2,3-triazol-4- yl)methyl)-2-(hydroxymethyl)-5-methoxy-4-(4-(2,3,4- trifluorophenyl)-1H-1,2,3-triazol-1-yl)tetrahydro-2H- pyran-3-ol::US20240109930, Example 3.1.66.C::US20240109930, Example 3.1.66.D

SMILES CO[C@H]1[C@@H](Cc2cn(nn2)[C@@H]2CCOC[C@H]2F)O[C@H](CO)[C@H](O)[C@@H]1n1cc(nn1)-c1ccc(F)c(F)c1F

InChI Key InChIKey=QLHVJSUJZKIIGV-UHFFFAOYSA-N

Data  4 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 664557   

TargetGalectin-1(Human)
Idorsia Pharmaceuticals

US Patent
LigandPNGBDBM664557(US20240109930, Example 3.1.66.C | (2R,3R,4S,5R,6R)...)
Affinity DataIC50: 270nMAssay Description:Briefly, compounds are serially diluted in DMSO (working dilutions). ASF-coated 384well plates are supplemented with 22.8 μL/well of biotinylate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetGalectin-1(Human)
Idorsia Pharmaceuticals

US Patent
LigandPNGBDBM664557(US20240109930, Example 3.1.66.C | (2R,3R,4S,5R,6R)...)
Affinity DataIC50: 310nMAssay Description:Briefly, compounds are serially diluted in DMSO (working dilutions). ASF-coated 384well plates are supplemented with 22.8 μL/well of biotinylate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Idorsia Pharmaceuticals

US Patent
LigandPNGBDBM664557(US20240109930, Example 3.1.66.C | (2R,3R,4S,5R,6R)...)
Affinity DataIC50: 40nMAssay Description:Briefly, compounds are serially diluted in DMSO (working dilutions). ASF-coated 384well plates are supplemented with 22.8 μL/well of biotinylate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Idorsia Pharmaceuticals

US Patent
LigandPNGBDBM664557(US20240109930, Example 3.1.66.C | (2R,3R,4S,5R,6R)...)
Affinity DataIC50: 20nMAssay Description:Briefly, compounds are serially diluted in DMSO (working dilutions). ASF-coated 384well plates are supplemented with 22.8 μL/well of biotinylate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent